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The adenylate cyclase responsiveness of transformed fibroblastic and epithelial cell lines to forskolin, 
fluoride, guanine nucleotides and cholera toxin was reduced compared to their parental counterparts. This 
phenomenon was observed in lines transformed by either RNA or DNA tumor viruses, and in the case 
of polyoma virus, coincided with the expression of middle T antigen. The data suggest hat decreased 
responsiveness of adenylate cyclase to non-hormone activators is a general consequence of viral 
transformation and may be related to viral regulation of protein kinase activity. 
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1. INTRODUCTION 
Numerous changes accompany transformation 
of various cell types with RNA tumor viruses, in- 
cluding alterations of membrane lipids [ 11, pro- 
teins [2], adhesive properties [3] and growth 
characteristics [4]. Morphological changes which 
accompany transformation of certain cell lines 
have been correlated with decreased intracellular 
CAMP levels: usually a consequence of decreased 
adenylate cyclase activity rather than increased 
phosphodiesterase activity (review [5]). Virtually 
all of the above studies were done with fibroblasts, 
transformed by RNA tumor viruses. Since current 
methodology permits correlation of cellular effects 
of transformation with specific viral gene pro- 
ducts, it is possible to extend previous studies and 
to compare the effects of transformation with 
either RNA or DNA viruses on fibroblasts and dif- 
ferentiated epithelial cells. 
Dr Thomas Shih (NCI); normal rat kidney cells 
(NRK) and a line transformed with Kirsten sar- 
coma virus (NRK-KSV) or the Schmitt-Rupin 
strain of Rous sarcoma virus (NRK-RSV) were 
provided by Dr Ira Pastan @ICI); Chinese 
hamster lung cells (CHL) and a line of CHL 
transformed with simian virus 40 (CHL-SV 40) 
and a line of CHL transformed with simian virus 
40 (CHL-SV 40) were from Dr George Martin 
(NIADDK); rat embryonic fibroblasts (RAT-l) as 
well as transformed lines were from Dr Yoshiki Ito 
(NIAID). Rat-l lines transformed with specific 
polyoma virus gene products were as follows; PyT, 
wild-type polyoma virus, 1837, large T antigen, 
MT 2-6, middle T antigen, dl 23-14, wild-type 
polyoma virus lacking the specific substrate for 
phosphorylation. All lines were maintained in 
Dulbecco’s modified minimal essential media with 
5% fetal bovine serum (HYClone) in a humidified 
atmosphere in 5% COZ. 
2. MATERIALS AND METHODS 2.2. Membrane preparation 
2.1. Cell culture 
Madin Darby canine kidney cells (MDCK) and a 
line of MDCK cells transformed with Harvey sar- 
coma virus (MDCK-HSV) were kindly provided by 
Sucrose gradient purified membranes were 
prepared as in [6]. To prepare partially purified 
membranes cells were scraped, homogenized in 
hypotonic medium and debris removed by cen- 
trifugation at 500 x g. The supernatant was then 
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centrifuged at 50000 x g for 20 min to pellet the 
partially purified membranes. 
2.3. Adenylate cyclase 
Adenylate cyclase activity was measured as in [7] 
with 20-3Opg purified membranes/lOOpl in a final 
concentration of Tris-acetate (pH 7.5), 100 /cM 
ATP, 10 mM MgCL, 100 PM CAMP, 5 mM 
creatine phosphate, 0.2 mg/ml creatine 
phosphokinase, 1OOpM dithiothreitol, lO#M GTP 
and 1 &i [32P]ATP, for 10 min at 30°C. Cyclic 
AMP was separated from ATP as in [7]. 
2.4. ADP-ribosylation 
Purified membranes were incubated under 
adenylate cyclase conditions ([32P]ATP was omit- 
ted) in the presence of 1 mM thyrnidine, 10 ,uM 
NAD+ and 3 &i [32P]NAD+ with 100 pg/ml ac- 
tivated cholera toxin [8] for 15 min at 30°C. ADP- 
ribosylated products were visualized by 
autoradiography of proteins separated as in [9]. 
3. RESULTS AND DISCUSSION 
The hormone responsive adenylate cyclase 
system is composed of 3 major components [lo]. 
The catalytic component (C) converts Mg2+-ATP 
to CAMP. Its activity is regulated by guanine 
nucleotide regulatory proteins (N, and Ni), which 
interact with stimulatory (R,) or inhibitory (Ri) 
hormone receptors. Various compounds can ac- 
tivate adenylate cyclase by direct interaction with 
C or N,. Cholera toxin catalyzes the ADP- 
ribosylation of N, [l I], resulting in the persistent 
activation of C. Gpp(NH)p, the non-hydrolyzable 
analogue of GTP, specifically binds to N,, while 
fluoride, whose precise site of action is unknown, 
seems to require the presence of a functional N, 
[12] to activate adenylate cyclase. Most adenylate 
cyclase systems also can be maximally activated by 
forskolin [13], which does not require functional 
N, [14], although its site of action is not known 
1151. 
Purified plasma membranes were prepared [6] 
2-3 days after cells became confluent to eliminate 
density effects on adenylate cyclase activity. There 
was no detectable phosphodiesterase activity in 
such preparations. Membranes from MDCK-HSV 
cells exhibited activity in the presence of both 
Mg2+ and Mn2+ similar to parental cells, but the 
activation of adenylate cyclase by fluoride, 
Gpp(NH)p, cholera toxin and forskolin was reduc- 
ed (fig.1). In contrast, with NRK-KSV and CHL- 
SV 40, basal as well as stimulated adenylate cyclase 
activity was reduced in the transformed lines 
(fig. 1). The adenylate cyclase responsiveness of 
NRK-RSV was identical to that of the line 
transformed with KSV as compared to the parental 
line. 
The decreased responsiveness of transformed 
cells to forskolin, usually the most potent activator 
of adenylate cyclase, was not the result of decreas- 
ed potency of forskolin on transformed mem- 
branes. The KaCt for forskolin activation of 
adenylate cyclase (5 FM) was similar in both paren- 
tal and transformed MDCK and CHL membranes. 
Forskolin activation of all cell lines was maximal at 
1OOpM (not shown). 
The catalytic (C) and regulatory (N) components 
of adenylate cyclase are thought to exist in the 
membrane as separate entities, which interact to 
stimulate ATP conversion to CAMP only after N is 
activated [16]. Cholera toxin covalently labels the 
M, 45 000 subunit of N, with ADP-ribose [I 11, per- 
mitting quantitation of this component. However, 
the labeling pattern of MDCK-HSV and NRK- 
KSV was identical to that of their respective paren- 
tal counterparts (not shown), suggesting that the 
quantity of N, is not limiting for adenylate cyclase 
activation. 
Given the current understanding of the 
aaenylate cyclase system, the simplest explana- 
tions of the data would be that transformation: 
(i) affects N, domains relevant to Its interaction 
with non-hormone activators; 
(ii) affects Ni such that its activity is enhanced 
relative to N,; 
(iii) affects C such that its ability to be maximally 
stimulated is reduced; or 
(iv) results in an as yet unidentified plasma mem- 
brane component which alters N, or Nr regula- 
tion of C or C activity itself. 
Studies are currently underway to explore these 
various possibilities. 
To define specific viral gene products responsi- 
ble for reduced adenylate cyclase activity, Rat-l 
cells, a line of embryonic rat cells, and lines of 
Rat-l cells transformed with plasmids containing 
single gene products of polyoma virus [17], were 
used. Polyoma virus, a DNA tumor virus, codes 
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Fig. 1. Adenylate cyclase activity of normal and 
transformed MDCK, NRK and CHL cells. Adenylate 
cyclase activity of purified membranes was measured as 
described. The final concentrations of activators in the 
assay were all maximally stimulating: 2 mM Mr?+ 
replaced Mg’*, 100 pg/ml cholera toxin (CT), 100 PM 
forskolin (Fo), la mM fluoride (Fl), 1OOpM Gpp(NH)p 
(GN). Cholera toxin was activated as in [8], and 1 mM 
NAD+ was present during the assay. There was no effect 
of NAD+ on adenylate cyclase activity in the absence of 
cholera toxin. 
for 3 well defined tumor antigens, designated as 
small, middle and large T antigens [I 71. Middle T 
antigen, which seems to be localized on the plasma 
membrane [181, is required for the maintenance of 
the oncogenic state [ 191. Large T antigen, a DNA 
binding protein, is required for viral DNA replica- 
tion and is responsible for the expression of altered 
growth characteristics which accompany transfor- 
mation [20], but alone is not a transforming pro- 
tein. The function of the small T antigen is less well 
characterized [21]. Like MDCK cells, membranes 
of PyT cells, a line of Rat-l cells transformed with 
wild-type polyoma virus, were significantly less 
responsive to stimulators of adenylate cyclase (fig. 
2), although basal activity was similar to the paren- 
tal line. Membranes of 1837 cells (only large T an- 
tigen) exhibited responsiveness very similar to the 
parental line but membranes from MT 2-6 cells 
(only middle T antigen), exhibited almost total 
lack of all adenylate cyclase activity. A specific 
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Fig. 2. Adenylate cyclase responsiveness of Rat-l cells 
transformed with polyoma virus. Conditions were iden- 
tical to those of fig.1. 
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phosphorylated in vitro (221. The adenylate cyclase 
activity of a Rat-l line (dl23-14), transformed with 
virus lacking the nonapeptide around this tyrosine 
residue [23] was very similar to that of MT 2-6 
(fig.2). While the transformation frequency of this 
deletion mutant is not significantly altered, 
decreased expression of the transformed 
phenotype is observed [24]. Therefore, although 
middle T is required for transformation, 
phosphorylation of middle T is not. It has also 
been demonstrated that phosphorylation of the 
transforming protein of RSV is not required for 
transformation [25]. The present studies (fig.2) 
suggest that like transformation, the effect on 
adenylate cyclase requires the viral transforming 
protein, but that phosphorylation of middle T is 
not relevant to either process. 
It is surprizing that depressed adenylate cyclase 
activity is observed in epithelial cells (MDCK and 
CHL) or fibroblasts (NRK and Rat-l) transformed 
with RNA (HSV, RSV, KSV) or DNA (SV 40 and 
polyoma) tumor viruses. Cell lines transformed 
with KSV and HSV express the viral ras gene pro- 
duct (p 21) associated with the plasma membrane 
[26], a GTP binding protein capable of 
autophosphorylation [27]. Lines transformed with 
RSV express the viral STC [28] gene product (pp 60) 
also associated with the plasma membrane [29], 
which exhibits tyrosine-specific protein kinase ac- 
tivity [30]. SV 40 transformation is accompanied 
by numerous changes in protein phosphorylation, 
several of which are also observed following 
transformation with RSV [31]. The nature of these 
substrates and their relationship to transformation 
are unknown. The middle T antigen of polyoma 
virus [32] is also associated with the plasma mem- 
brane [33]. A tyrosine kinase activity is detectable 
in middle T immunoprecipitates [22]. Such im- 
munoprecipitates also contain proteins which cor- 
relate with the cellular homolog of STC (~~60) [34] 
and epidermal growth factor receptor kinase [35], 
suggesting that middle T may associate with and 
regulate the activity of these kinases. While it is 
tempting to propose that viral-dependent 
phosphorylation regulates adenylate cyclase activi- 
ty, this premise seems premature since the relation- 
ship between transformation and phosphorylation 
is not well defined at this point. 
Although an explanation for the depressed 
adenylate cyclase activity following viral trans- 
formation is not readily apparent, it does seem 
significant that viral transformation with a variety 
of different viruses in a number of different cell 
lines has profound effects on the adenylate cyclase 
system. It is possible that these alterations in 
adenylate cyclase activity are related to the produc- 
tion of transforming factors by cells transformed 
with RNA and DNA viruses [36]. Whether these 
changes confer some advantage on the transform- 
ed cells is not known. However, further study of 
the consequences of virally regulated protein 
kinase activity on adenylate cyclase and other 
cellular regulatory systems may provide insight in- 
to critical factors involved in and contributing to 
malignant transformation. 
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